Sign up today for an exclusive discount along with our 30-day GUARANTEE — Love us or leave, with your money back! Click here to become a part of our growing community and learn how to stop gambling with your investments. We will teach you to BE THE HOUSE — Not the Gambler!

Click here to see some testimonials from our members!

Analyst: Canopy Growth Looks Greener Than It Did 6 Weeks Ago

Courtesy of Benzinga

Analyst: Canopy Growth Looks Greener Than It Did 6 Weeks Ago

Over the past 12 months, Canopy Growth’s (NYSE: CGC) shares have fallen by half. 

The Analyst

Bank of America Merrill Lynch’s Christopher Carey reiterated a Neutral rating on Canopy Growth with a $23 price objective. 

The Thesis

The risk-reward profile for Canopy’s second-quarter looks much better than it did six weeks ago, Carey said in a Wednesday note. (See his track record here.) 

Bank of America downgraded the stock Sept. 27. 

The analyst predicts the company will reveal its new CEO when it reports second-quarter results Nov. 14.

That development, together with recently lowered estimates, could form a low bar, he said. 

“Reiterate Neutral, on near-term execution risks and potentially lofty Street estimates, balanced by an industry leading balance sheet.”

The second-quarter consensus sales estimate is CA$102 million ($77.4 million) versus CA$97 million in the prior quarter, Carey said. 

Bank of America is expecting a figure beneath the Street estimate: CA$94 million.

The Street’s out-year estimates present a “best case scenario,” the analyst said. 

“While we think that setup has improved for FQ220, we view sustainable upside in Canopy shares as challenging, particularly against a backdrop of Street estimates that we think are too high.”

Price Action

Canopy Growth shares were up 0.7% at $20 at the time of publication. 

Related Links: 

Cannabis Stock Gainers And Losers From November 5, 2019

Large Option Trader Betting On Canopy Growth Bounce Ahead Of Earnings

Latest Ratings for CGC

Date Firm Action From To
Oct 2019 Maintains Overweight
Oct 2019 Downgrades Buy Neutral
Oct 2019 Downgrades Hold Underperform

View More Analyst Ratings for CGC


View the Latest Analyst Ratings

Posted-In: Bank of America Merrill LynchAnalyst Color Cannabis News Price Target Reiteration Markets Analyst Ratings Best of Benzinga


Do you know someone who would benefit from this information? We can send your friend a strictly confidential, one-time email telling them about this information. Your privacy and your friend's privacy is your business... no spam! Click here and tell a friend!





You must be logged in to make a comment.
You can sign up for a membership or get a FREE Daily News membership or log in

Sign up today for an exclusive discount along with our 30-day GUARANTEE — Love us or leave, with your money back! Click here to become a part of our growing community and learn how to stop gambling with your investments. We will teach you to BE THE HOUSE — Not the Gambler!

Click here to see some testimonials from our members!